BOD Australia Health Care
Biotech Cannabis Healthcare North America Pharmaceuticals United Kingdom

$0.069 0.004 (6.15%)

High $0.07	Low $0.07	Trades 11	Turnover $3,477	Volume 53,435
30 June 2023 at 4:10pm

Market Cap (19-Sep) $4,256,112 (0th)	Close (30-Jun) $0.069 0 (0%)	Volume (30-Jun) 53,435	Shortsold (24-Oct) 1,681 (0.00%) (629th)
52w High $0.024	52w Low $0.024	P/E -	EPS -0.06

Short Interest

ASIC data, 24 Oct 2023

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

629th

of 709 shorted ASX stocks

Peak Short

0.01%

Jun 2023

Days to Cover

View full short position history →

	Subject
	BOD BOD Ann: Appendix 3B - extended closing date for Entitlement Offer
	1 (current) 2 3
	BOD BOD Ann: Change in substantial holding
	BOD BOD Ann: Extension of Closing Date for Entitlement Offer
	BOD BOD Ann: Entitlement Offer Booklet
	BOD BOD Ann: Entitlement Offer - Letter to Eligible Shareholders
	BOD BOD Ann: Entitlement Offer - Letter to Ineligible Shareholders
	BOD BOD Ann: Section 708A cleansing notice - Placement
	BOD BOD Ann: Application for quotation of securities - BOD
	BOD BOD Ann: Appendix 3B Entitlement Offer - amended issue date
	BOD BOD Ann: Appendix 3B Entitlement Offer
	BOD BOD Ann: Proposed issue of securities - BOD
	BOD BOD Ann: Section 708AA(2) cleansing notice
	BOD BOD Ann: Investor Presentation
	BOD BOD Ann: Capital raising and transformational acquisition
	BOD BOD Ann: Appendix 4E and full year statutory accounts
	BOD BOD Ann: Bod to acquire Aqua Phase
	BOD BOD Ann: Trading Halt
	BOD BOD Ann: Bod awarded US Hemp Authority certificate for CBD extract
	BOD BOD Ann: Quarterly activities report and Appendix 4C
	BOD BOD Ann: CBD Schedule 3 product to be launched via SAS-B channel
	BOD BOD Ann: Study highlights efficacy of new medicinal cannabis product
	BOD BOD Ann: Final Director's Interest Notice
	BOD BOD Ann: Non-Executive Chairman Transition
	BOD BOD Ann: First patients enrolled for Schedule 3 CBD clinical trial
	BOD BOD Ann: Quarterly Activities Report and Appendix 4C
	BOD BOD Ann: First patients enrolled for Long COVID study
	BOD BOD Ann: Initial Director's Interest Notice - David Baker
	BOD BOD Ann: Final Director's Interest Notice - Simon O'Loughlin
	BOD BOD Ann: Appointment and resignation of Non-Executive Director
	BOD BOD Ann: Half Year Activities Report
	BOD BOD Ann: Half Year Accounts and Appendix 4D
	BOD BOD Ann: Novel food application accepted by UK Food Service Agency
	BOD BOD Ann: Quarterly Activities Report and Quarterly Cash Flow Report
	BOD BOD Ann: Ethics approval received for Schedule 3 clinical trial
	BOD BOD Ann: Authorisation secured for UK based long covid clinical trial
	BOD BOD Ann: Notification regarding unquoted securities - BOD
	BOD BOD Ann: Results of Meeting
	BOD BOD Ann: CEO presentation to AGM
	BOD BOD Ann: Appendix 4G and Corporate Governance Statement
	BOD BOD Ann: Annual Report to shareholders
	BOD BOD Ann: Quarterly Activities Report and Appendix 4C
	BOD BOD Ann: Notice of Annual General Meeting/Proxy Form

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.02	0	0.00 (0.00%)
12-Sep	$0.02	0	0.00 (0.00%)
11-Sep	$0.02	0	0.00 (0.00%)
05-Sep	$0.02	0	0.00 (0.00%)
04-Sep	$0.02	0	0.00 (0.00%)
03-Sep	$0.02	0	0.00 (0.00%)
29-Aug	$0.02	0	0.00 (0.00%)
28-Aug	$0.02	0	0.00 (0.00%)
22-Aug	$0.02	0	0.00 (0.00%)
21-Aug	$0.02	0	0.00 (0.00%)
15-Aug	$0.02	0	0.00 (0.00%)
14-Aug	$0.02	0	0.00 (0.00%)
07-Aug	$0.02	0	0.00 (0.00%)
31-Jul	$0.02	0	0.00 (0.00%)
30-Jul	$0.02	0	0.00 (0.00%)
0 up, 0 down, and 15 flat days

BOD Australia Health Care
Biotech Cannabis Healthcare North America Pharmaceuticals United Kingdom

Short Interest

Followers

Prices

Announcements

End of Day Prices

BOD BOD Australia Health Care Biotech Cannabis Healthcare North America Pharmaceuticals United Kingdom

Short Interest

Followers

Prices

Announcements

End of Day Prices

BOD Australia Health Care
Biotech Cannabis Healthcare North America Pharmaceuticals United Kingdom